Recalls / —
—#187210
Product
Remel Bile Esculin Azide Agar w/ 6mcg/ml Vancomycin, Product #R01186, 10/package - Product Usage: use in qualitative procedures as a screening method for primary isolation and presumptive identification of vancomycin-resistance enterococci (VRE) from surveillance cultures.
- FDA product code
- JSO — Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar
- Device class
- Class 2
- Medical specialty
- Microbiology
- 510(k) numbers
- K972359
- Affected lot / code info
- Lot #248035, Exp. 2021-04-27
Why it was recalled
The media allows growth of E. faecalis ATCC 29212 with blackening of the media.
Root cause (FDA determination)
Mixed-up of materials/components
Action the firm took
The recalling firm issued customer letters dated 4/22/2021 via first class mail to its direct accounts.
Recalling firm
- Firm
- Remel Inc
- Address
- 12076 Santa Fe Trail Dr, Lenexa, Kansas 66215-3519
Distribution
- Distribution pattern
- US Nationwide distribution in the states of AZ, CA, CO, CT, GA, IA, IL, IN, MA, MI, MN, MO, NC, ND, OH, OR, PA, SD, TN, TX, and VA. There was government distribution and no military or foreign distribution.
Timeline
- Recall initiated
- 2021-04-22
- Terminated
- 2023-08-08
- Status
- —
Source: openFDA Device Recall endpoint. Recall record ID #187210. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.